medigraphic.com
Boletín Clínico de la Asociación Médica del Hospital Infantil del Estado de Sonora

2011, Number 1

<< Back Next >>

Bol Clin Hosp Infant Edo Son 2011; 28 (1)

Prolonged Fever in Pediatric Inmune Diseases Diagnosis and Inmunological Alterations

Arroyave-Hernández CM

Language: Spanish
References: 40
Page: 23-26
PDF size: 36.90 Kb.


ABSTRACT

An increase of normal body temperature called fever, is one of the most common signs in pediatric pathology. However even with new molecular laboratory technology, sometimes is difficult to find its origin. Out of one hundred cases 47% have an infection, 16% a neoplasia, 8% connective tissue diseases and up to 14% have not diagnosis. We present some fever characteristic and immunologic abnormalities in rheumatic fever, juvenile rheumatoid arthritis, systemic lupus erythematosus, mixed connective tissue disease and juvenile dermatomyoisitis.


REFERENCES

  1. Mackowiak P. Concepts of fever. Arch Inter Med 1998; 158: 1870-81.

  2. Dalal S, Zhokovsky D. Pathophysiology and management of fever. J. Suppor. Onco 2006; 4: 9-16.

  3. Thompson H. Fever: a concept analysis. J Adv Nurs 2005; 51: 484-92.

  4. Benedetti M. Fiebre en la edad pediátrica. Acta Pediatr Lat. 1994; 47: 338-48.

  5. Conrad WL, Voorhis W. Review nomenclature and biologic significance of cytokines involved in inflammation and the host immune response. J Infect Dis 1995; 172: 1573-80.

  6. Lifshitz A. Fever: friend or foe? Arch Med Res 1994; 25: 283-6.

  7. Luheshi G, Rothwell N. Cytokines and fever. Int Arch Allergy Immonol 1996; 109301-7.

  8. Kluger MJ. Historical aspects of fever and its role in disease. En: Cox B, Lomax P. Thermorregulatory mechanisms and their therapeutic implications. Basel: Karger, 1980: 65-70.

  9. Kluger MJ, Kozak W, Conn CA, León LR, Soszynski D. The adaptative value of fever. Infect Dis Clin North Amer 1996; 10: 1-20.

  10. Hiramoto R, Rogers C, Dimissie S, Hsuch CM, Hiramoto M, Lorde J et al. The use of conditioning to probe for CNS pathways that regulate fever and NK cells activity. Int J Neurosci 1996; 84: 229-45.

  11. Nademi Z, Clark J, Richards CG, Walshaw D, Cant AJ. The causes of fever in children attending hospital in the north of England. J Infect 2001; 43: 221-5.

  12. Akpede G, Akenzua G. Management of children with prolonges fever of unknown origin and difficulties in the management offever of unknown origin in children in developing countries. Pediatr Drug 2001; 3: 247.

  13. Hayani A, Mahioney OH, Ferbach DJ. Role of bone marrow examination in the child with prolonged fever. J Pediatr 1990; 16: 19-20.

  14. Steele RW, Jones SM, Lowe BA, et al. Usefulness of scanning procedures for diagnosis of fever of unknown origin in children. J Pediatr 1991; 119: 525-30.

  15. Pasic S, Minic A, Djutric P. Fever of unknown origin in 185 paediatric patients: a single-centr e experience. Acta Paediatr 2006; 95: 463-6.

  16. Cunha B. Fever of unknown origin: clinical overview of classical and current concepts. Infect Dis Clin North America. 2007; 21: 867-915.

  17. Jones TD. Diagnosis of rheumatic fever. Jama 1944; 126: 481-84.

  18. Special report: Jones Criteria (revised) for guidance in the diagnosis of rheumatic fever. Circulation 1984; 69: 204 A.

  19. Chopra P and Gulwani H. Pathology and pathogenesis of rheumatic heart disease. Indian J Pathol Microbiology. 2007; 50: 685-97.

  20. Goldbach-Mansky R. Blocking interleukin-1 in rheumatic diseases. Ann N Y Acad Sci 2009; 1182: 111-23.

  21. Azevedo PM, Bauer R, Caparbo Vde F, Silva CA, Bonfá E and Pereira RM. Interleukin-1 receptor antagonist gene (IL1RN) polymorphism possibly associated to severity of rheumatic carditis in a Brazilian cohort. Cytokine 2010; 49: 109-13.

  22. Cassidy JT, LevinsonJE, Brewer EJ Jr. The development of classification criteria for children with juvenile rheumatoid arthritis. Bull Rheum Dis 1989; 38: 5.

  23. Carreño R y del Rio B. En: Reumatologia pediátrica. Artritis reumatoide Juvenil. México: Interamericana-McGraw Hill 1994 87-111.

  24. Villanueva J, Lee S, Giannini EH, Graham TB, Passo MH, Filipovich A, Grom AA. Arthritis Res Ther 2005; 7: R30-R37.

  25. Mangge H, Kenzian H, Gallisti S, Neuwirth G, Liebmann P, et al. Serum cytokines in juvenile rheumatoid arthritis. Correlation with conventional inflammation parameters and clinical subtypes. Arthritis & Rheum 1995; 38: 221-20.

  26. Yilmaz M, Kendirli SG, Altintas D et al. Cytokine levels in serum of patients with juvenile rheumatoid arthritis. Cli Rheumatol 2001; 20: 30-6.

  27. Madson KL, Moore TL, Lawrence JM., et al. Cytokine levels in serum and synovial fluid of patients with juvenile rheumatoid arthritis. J Rheumatology 1994; 21 2359.

  28. Tan EM, Cohen AS, Fries JF, et al The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum., 1982; 25: 1271-7.

  29. Arroyave C M, de la Garza P, Benavides ME. En: Lupus el gran simulador Ed: Cuellar 2000 México p 50-52,70-78.

  30. Anolik JH. B cell biology and dysfunction in SLE. Bull NYU Hosp Jt Dis 2007; 65: 182-6.

  31. Nagy G, Koncz A, Perl A. T and B cell abnormalities in systemic lupus erythematosus. Crit Rev Immunol. 2005; 25: 123-40.

  32. Sharp GC, Irvin WS. Mixed connective tissue disease. An apparently distinct rheumatic disease syndrome associated with a specific antibody to an extractable nuclear antigen (ENA). AMM J of Med 1972; 52: 148.

  33. Souvert J, Chudwin D, Ware K, col. Clinical and laboratory findings in childhood mixed connective tissue disease. Presence of antibody to ribonucleoprotein contain the small nuclear ribonuclear acid U1. J Pediatr 1983; 63: 92-107.

  34. Bohan A, Peters JB. Polymyositis and dermatomyositis. N Engl J Med 1975; 292: 344-7 y 403-7.

  35. Cassidy JT, Petty RE (eds). Juvenil dermatomyositis. En : Textbook of pediatric rheumatology, New York: Churchill Livingstone, 1990:331-75.

  36. Marie I, Lahaxe L, Benveniste O, Delavigne K, Adoue D, et al. Long-term outcome of patients with polymyositis/dermatomyositis and anti-PM-Scl antibody. Br J Dermatol 2010; 162: 337-44.

  37. Plotz H, Dalakas M, Left R, Love LA, Miller FN, Cronin ME.Current concepts in the idiopathic inflammatory myopathies: polimyositis, dermatomyositis and related disorders. An Intern Med 1989;111: 143-57.

  38. Faure MA, Rodriguez RS, Sienra JL, del Rio B, Gomez MP. Dermatomiositis juvenil: características clínicas, inmunológicas y terapeúticas. Bol Med Hosp Inf Mex 1993.

  39. Jain A, Sharma MC. Sarkar C, Bhatia R, Singh S, Gulati S and Handa R. Detection of the membrane attack complex as a diagnostic tool in dermatomyositis. Acta Neurol Scand 2010:17.

  40. Pachman LM, Maryjowsky MC. Juvenil dermatomyositis and polymyositis. Clin Rheuma Dis 1984;10:95-115.




2020     |     www.medigraphic.com